针对非小细胞肺癌的向治疗的进展:目前的进展和未来的方向
Supriya Peshin1, Ehab Takrori2, Joseph H Yazji3
1Department of Internal Medicine, Norton Community Hospital, Norton, VA 24273, USA.
International journal of molecular sciences
|December 11, 2025
概括
向疗法正在通过向特定突变来彻底改变非小细胞肺癌 (NSCLC) 治疗. 本综述详细介绍了KRAS,EGFR,ALK和其他可操作的目标的进展,为患者提供了新的希望.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 向疗法已经改变了非小细胞肺癌 (NSCLC) 管理,改善了生存率.
- 迅速发现致癌驱动因素需要在临床实践中不断更新.
- 可操作的突变为NSCLC提供了个性化治疗策略的机会.
研究的目的:
- 审查针对NSCLC可操作突变的向治疗的不断变化的格局.
- 要突出KRAS向治疗的最新进展,包括非G12C突变和泛RAS抑制剂.
- 讨论针对EGFR,ALK,MET,HER2,RET,ROS1,FGFR和TROP-2变化的新兴疗法.
主要方法:
- 最近的临床试验和研究出版物的文献综述.
- 对NSCLC中特定瘤原因驱动因素的治疗策略的分析.
- 综合有关已确立和新型向药物的信息.
主要成果:
- 在针对KRAS的疗法,包括非G12C和泛RAS抑制剂方面取得了显著进展.
- 对于EGFR和ALK变化的治疗标准正在不断发展.
- 对MET,HER2,RET,ROS1,FGFR和TROP-2的新兴疗法显示出有希望.
结论:
- 针对NSCLC的向治疗领域正在迅速发展,提供了更多的治疗选择.
- 克拉斯和TROP-2是最近发展的关键领域.
- 个性化医疗方法对于优化NSCLC患者的治疗结果至关重要.
关键词:
阿尔克 (ALK) 是一个在BRAF V600E中使用.欧洲农业基金会 (EGFR) 是一个基金.在HER2中,HER2是HER2.克拉斯 (Kras) 是一个国家.在MET中,MET是MET.在NSCLCLC中,我们可以看到.俄罗斯国家广播电视台 (NTRK)在RET的基础上,RET是RET.在TROP-2中.非小细胞肺癌的肺癌.有针对性的治疗方法.更多相关视频
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.6K
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
8.3K
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Cancer Vaccines
929
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
929
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
